Latest News - Fungal Infections

Tuesday, July 31, 2018

LEO Pharma to Acquire Bayer Prescription Dermatology Business

LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription treatments for acne, fung…

Read the full story

Wednesday, July 11, 2018

Nanotechnology May Improve Onychomycosis, Cut Costs

Nanotechnology can improve efinaconazole treatment for onychomycosis and make it more cost effective, according to new research in the Journal of Drugs in Dermatology. Adam Friedman, MD, professor …

Read the full story

Wednesday, July 11, 2018

Life Sciences Industry Eyes $1.5 Trillion Milestone

The life sciences industry is nearing a $1.5 trillion milestone, according to an analysis from Frost & Sullivan. The firm’s Global Life Sciences Industry Outlook, 2018 report finds that…

Read the full story

Friday, May 11, 2018

Valeant is Becoming Bausch Health Companies, Inc.

Bausch Health Companies, Inc. will become the new name of Valeant Pharmaceuticals International, Inc., effective in July 2018. Based on the strong brand equity of the company’s businesses a…

Read the full story

Tuesday, August 08, 2017

Research on Nitric Oxide-Releasing Nanoparticles Reveals Promising Skin Infection Treatment

George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by der…

Read the full story

Wednesday, April 12, 2017

Novan: Positive Topline Results with Fungicidal SB208 in Phase 2 Trial

Novan, Inc. has announced positive topline results from their Phase 2 clinical trial with SB208, a topical, silicone based-gel under development for the treatment of infections caused by dermatop…

Read the full story

Tuesday, April 04, 2017

Novan Forms New Advisory Council Focused on Nitric Oxide Technologies in Dermatology

Novan, Inc.  has formed an Advisory Council comprised of key opinion leaders with broad expertise in dermatology. These leading physicians will provide medical advice and drug-development insight…

Read the full story

Wednesday, March 01, 2017

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study which appears online in JAMA Dermatology. For the study, researchers estimat…

Read the full story

Wednesday, March 01, 2017

AAD Launches SkinSerious Campaign

The American Academy of Dermatology is launching a new campaign to raise awareness of the breadth of serious skin diseases as well as the critical role dermatologists play in an era of team-based heal…

Read the full story

Thursday, November 17, 2016

Derms Commonly Misdiagnose Fungal Skin Infections

Fungal skin infections may be commonly misdiagnosed, according to a survey in the Journal of the American Academy of Dermatology. George Washington University (GW) dermatologist Adam Friedman, MD a…

Read the full story

Friday, October 07, 2016

At-Home Nail Fungus Treatment Now Available From iSkinProducts

Cure-Ex nail fungus laser treatment device is now available from online beauty retailer, iSkinProducts. The portable device can be used on fingernails or toenails and a user can use the Cure-Ex laser …

Read the full story

Monday, August 01, 2016

Deadline Approaching: Apply for Grant from La Roche-Posay’s "Dermatologist from the Heart" Program

La Roche-Posay plans to continue its "Dermatologist from the Heart" program for the fifth year. As part of the program, La Roche-Posay provides grant money up to $10,000 to fund community…

Read the full story

Thursday, July 21, 2016

Novan: First Patient Dosed in Phase 2 Anti-Fungal Program

The first patient has been dosed in Novan's clinical program to evaluate the efficacy and safety of topical nitric oxide product candidate SB208 in the treatment of infections caused by dermatophy…

Read the full story

Friday, April 15, 2016

Recent AAD Meeting Boasts Record Attendance

More than 18,500 people from 107 countries attended the American Academy of Dermatology’s 74th Annual Meeting held in Washington, DC in early March 2016. The meeting featured more than 375 ed…

Read the full story

Wednesday, December 02, 2015

Aqua Pharmaceuticals Acquires US Rights to Veltin Gel and Altabax Ointment

Aqua Pharmaceuticals, LLC acquired the US rights to two dermatology products -- Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025% and Altabax (retapamulin) Ointment 1%, after Almirall, par…

Read the full story
Load More